logo_2
  • The Programme
  • The Club
  • Events
  • News
  • Reports
  • Subscribe
    logo_1

    EIC Scaling Club News

    AI in Health Tech

    AI in health tech: EIC Scaling Club companies advancing diagnosis, care and treatment

    Health sector Cardiovascular Therapies New Biotech Platforms AI MedTech Cancer treatment early cancer detection AI in healthcare health tech
    Jan 13, 2026 11:46:12 AM
    Convert Pharmaceuticals interview

    Convert Pharmaceuticals: Tackling cancer’s toughest barrier

    Health sector biotech New Biotech Platforms 120 companies Cancer treatment
    Dec 15, 2025 1:29:33 PM
    Glycanostics interview

    Glycanostics: A non-invasive solution for detecting 11 types of cancer

    Health sector New Biotech Platforms 120 companies MedTech Cancer treatment early cancer detection
    Nov 11, 2025 2:50:17 PM
    Elypta interview

    Elypta: Pioneering metabolism-based liquid biopsy for earlier cancer detection

    Health sector New Biotech Platforms 120 companies MedTech Cancer treatment
    Sep 19, 2025 2:37:55 PM
    Sensius interview

    Sensius: Building the fourth pillar of cancer treatment

    New Biotech Platforms 120 companies MedTech Cancer treatment
    Sep 4, 2025 3:10:17 PM
    contextflow interview

    contextflow: Empowering radiologists with AI-driven solutions

    Health sector Video interview Cardiovascular Therapies 120 companies MedTech Cancer treatment
    Mar 5, 2025 1:58:24 PM
    Asgard Therapeutics Interview

    Asgard Therapeutics: A new era in cancer treatment

    Video interview New Biotech Platforms 120 companies MedTech Cancer treatment
    Jan 29, 2025 4:09:14 PM
    footer_logo

    This project has received funding from the European Union, under Grant Agreement Nº 101114582.

    Follow us!
    Group (1)
    c
    Vector (8)
    • Contact
    • Privacy
    • · Newsletter Archive
    • FAQ
    • Terms & Conditions

    This project has received funding from the European Union, under Grant Agreement Nº 101114582.

    © 2026 EIC Scaling Club. All rights reserved.